Transforming Data Into Action

Empowering life sciences firms with strategic clarity for competitive advantage.

Our Solutions

Early Stage Commercial Strategy & New Product Planning

Crafting robust strategies and plans to maximize the potential of your new products from inception to market launch.

Competitive Intelligence, Strategy, and Response Modelling

Providing actionable insights and strategic responses to stay ahead of the competition and navigate market challenges effectively.

Go-to-Market Strategy & Operating Model Development

Designing effective market entry strategies and operational frameworks to ensure successful product launches and sustainable growth.

Launch Readiness & Commercial Excellence

Ensuring your product is fully prepared for market launch with optimized strategies, executing the right actions at the right time for sustained success.

Welcome to Pharmamosaic

Our Mission

At Pharmamosaic, we empower life sciences organizations with strategic insights and tailored solutions. With over 15 years of experience, we specialize in vaccines, specialty and rare diseases, and small molecule medicines. Through co-creation and collaboration, we transform data into actionable strategies, driving success in competitive markets.

Our Vision

To be a leading advisory partner in the life sciences industry, known for our deep expertise, innovative solutions, and unwavering commitment to our clients' success. We strive to advance public health by helping our clients bring life-changing therapies to patients around the world.

Our Values

  1. Collaboration: We believe in the power of working together, fostering strong partnerships with our clients to achieve shared goals.

  2. Innovation: We embrace innovative approaches and solutions to stay ahead in the dynamic life sciences landscape.

  3. Decision Relevance: We ensure our insights and strategies are directly applicable, providing practical value and impact.

  4. Excellence: We are committed to delivering the highest quality of work, consistently exceeding expectations.

  5. Impact: We focus on making a meaningful difference in life sciences by supporting the development and commercialization of life-changing therapies.

Case Study: A US-based biotech in need of an EU GTM strategy

Our client’s challenge:

A leading biotech vaccine developer with significant success in the US market sought to expand its footprint into Europe. With a new vaccine ready for distribution, the company faced the challenge of evaluating the diverse European market, understanding regulatory requirements, and developing a strategic approach to effectively penetrate this new territory. Their goal was to establish a robust presence across the EU, ensuring successful distribution and market acceptance of their vaccine.

The Pharmamosaic approach:

Pharmamosaic embarked on a comprehensive market analysis to assess the opportunities and challenges across various European countries. We conducted in-depth research into market dynamics, competitive landscapes, and regulatory environments. Our team of experts leveraged their extensive knowledge of the life sciences industry to identify key market drivers and potential barriers. Through a series of strategic workshops and stakeholder interviews, we gathered valuable insights and aligned our approach with the client's objectives and vision for their EU expansion.

Our Solution:

Based on our thorough analysis, Pharmamosaic crafted a detailed go-to-market strategy tailored to the European context. We recommended an operating model that included:

  1. Market Segmentation: Prioritizing countries with the highest potential for rapid uptake based on healthcare infrastructure, market demand, and regulatory pathways.

  2. Market Prioritization: Identifying key markets within Europe to focus initial efforts, ensuring resources were directed towards the most promising regions.

  3. Partnership Strategy: Identifying potential local partners for distribution, logistics, and marketing to leverage their existing networks and expertise.

  4. Resource Allocation: Advising on the optimal allocation of resources, including sales force deployment and marketing investments, to maximize impact.

  5. Implementation Plan: Outlining a step-by-step plan for execution, including timelines, milestones, and key performance indicators (KPIs) to track progress.

Client Impact:

The implementation of Pharmamosaic's strategic recommendations resulted in a successful launch of the client's vaccine across multiple European countries. The partnership strategy enabled efficient distribution and market penetration, resulting in rapid uptake of the vaccine. Within the first year, the client established a strong EU footprint, with significant market share gains and increased brand recognition. Our strategic approach not only facilitated their entry into the European market but also positioned them for sustained growth and long-term success in the region.

Case Study: A global pharma company wanted to evaluate the opportunity in a new indication

Our client’s challenge:

A global pharmaceutical company, renowned for its advancements in neurology, sought to evaluate the potential of extending the indication of one of its key products. The company needed to determine whether the investment required for this extended indication would yield substantial returns. They faced the challenge of assessing the global market opportunity, understanding the competitive landscape, and estimating the potential revenue and market share for the new indication.

The Pharmamosaic approach:

Pharmamosaic initiated a comprehensive evaluation process to assess the global opportunity for the extended indication. Our approach included:

  1. Market Analysis: Conducting a detailed analysis of the global market to identify regions with the highest potential for the new indication. This included evaluating market size, growth rates, and healthcare infrastructure.

  2. Competitive Landscape: Analyzing existing and potential competitors in the neurology space to understand market dynamics and identify gaps and opportunities.

  3. Regulatory Assessment: Reviewing regulatory requirements and pathways in key markets to gauge the feasibility and timeline for approval of the extended indication.

  4. Stakeholder Interviews: Engaging with key opinion leaders, healthcare professionals, and industry experts to gather insights on the clinical and commercial potential of the extended indication.

  5. Financial Modelling: Developing robust financial models to project potential revenue, costs, and return on investment for the extended indication.

Our Solution:

Based on our thorough evaluation, Pharmamosaic provided a comprehensive report and strategic recommendations, which included:

  1. Global Market Opportunity: Identifying and prioritizing key markets with the highest potential for the extended indication.

  2. Competitive Positioning: Outlining strategies to differentiate the client’s product from competitors and capitalize on market opportunities.

  3. Commercial and Product Strategy: Providing a clear roadmap for product positioning, market entry tactics, pricing strategies, and distribution channels tailored to each key region.

  4. Commercialization Plan: Recommending a go-to-market strategy tailored to each key region, including market entry tactics, pricing strategies, and distribution channels.

  5. Investment Analysis: Presenting a detailed financial analysis to support decision-making, highlighting potential revenue streams, cost implications, and projected return on investment.

Client Impact:

Pharmamosaic's strategic insights enabled the client to make an informed decision regarding the extended indication. The comprehensive market evaluation revealed substantial global opportunities, highlighting regions with the highest potential for success. The competitive and regulatory assessments provided clarity on the feasibility of market entry and anticipated challenges. Armed with a robust commercialization plan and a clear investment analysis, the client was able to confidently move forward with the extended indication, positioning themselves for enhanced market presence and increased revenue in the neurology sector.

Ready to learn more?

Are you ready for tailored support that will make your organisation’s plans and strategies come to life? Connect with us today!